Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2021-12-09

FDA Approved: SODIUM OXYBATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for Sodium Oxybate (Hikma Pharmaceuticals USA Inc.), resulting in changes to the product's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sodium Oxybate (Sodium Oxybate)

Snippet

SUPPL AP for SODIUM OXYBATE (SODIUM OXYBATE)